Journals / Eurasian Journal of Medical Investigation / 2020 / Cilt: 4 - Sayı: 4

Evaluation of Effectiveness of Euroscore 2 in Patients Undergoing Isolated Coronary Artery Bypass and Isolated Mitral Valve Replacement Surgery

Pages
442–447
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Sensitivity was found to be 75%, and specificity was around 62%.Conclusion: The result of our study showed that Euroscore 2, a preoperative risk assessment test, has an effective use inthe determination of the mortality rate that may occur surgically in isolated coronary bypass and isolated mitral valvesurgery, although it showed slight differences from the procedures applied.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: In our study, we aimed to evaluate the results of our patients who underwent isolated coronary arterybypass graft (CABG) and isolated mitral valve replacement (MVR) surgeries under cardiopulmonary bypass (CPB) withone of the most common of these scoring systems, Euroscore 2.Methods: All patients who underwent consecutive isolated CABG and isolated MVR operations under CPB betweenMay 2012-March 2014 in Private Akay Hospital Cardiovascular Surgery Clinic were included in this study.
📊
Key Findings & Data:In this study,intraoperative deaths and deaths within 30 days postoperatively were considered as mortality.
💡
Conclusion & Impact:Sensitivity was found to be 75%, and specificity was around 62%.Conclusion: The result of our study showed that Euroscore 2, a preoperative risk assessment test, has an effective use inthe determination of the mortality rate that may occur surgically in isolated coronary bypass and isolated mitral valvesurgery, although it showed slight differences from the procedures applied.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: In our study, we aimed to evaluate the results of our patients who underwent isolated coronary arterybypass graft (CABG) and isolated mitral valve replacement (MVR) surgeries under cardiopulmonary bypass (CPB) withone of the most common of these scoring systems, Euroscore 2.Methods: All patients who underwent consecutive isolated CABG and isolated MVR operations under CPB betweenMay 2012-March 2014 in Private Akay Hospital Cardiovascular Surgery Clinic were included in this study. In this study,intraoperative deaths and deaths within 30 days postoperatively were considered as mortality. The patients' demographic data, preoperative risk factors, preoperative medication, postoperative data, postoperative complications,laboratory findings and observed mortality and morbidity records were obtained retrospectively from patient files andhospital database.Results: As a result of ROC analysis; In patients in the CABG group, the agreement of Euroscore expected mortality rateswith the actual mortality rates was found to be 81.3%, and this was statistically significant. Sensitivity was found to be80%, and specificity was around 70%.In patients in the MVR group, the agreement of Euroscore expected mortality rates with the actual mortality rates wasfound to be 77.1%, and this was statistically significant. Sensitivity was found to be 75%, and specificity was around 62%.Conclusion: The result of our study showed that Euroscore 2, a preoperative risk assessment test, has an effective use inthe determination of the mortality rate that may occur surgically in isolated coronary bypass and isolated mitral valvesurgery, although it showed slight differences from the procedures applied.

🔖

Cite This Article

EROL, G., SİCİM, H., KARTAL, H., ARSLAN, G., MUNGAN, U., GÜNAY, C., OZ, B. S., TAŞÖZ, I., DEMİRKIRAN, T. (2022). Evaluation of Effectiveness of Euroscore 2 in Patients Undergoing Isolated Coronary Artery Bypass and Isolated Mitral Valve Replacement Surgery. Eurasian Journal of Medical Investigation, Cilt: 4 - Sayı: 4, 442–447. https://ajindex.com/articles/508675

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Lebreton G, Merle S, Inamo J, Hennequin JL, Sanchez B, Rilos Z, et al. Limitations in the inter-observer reliability of EuroSCORE: what should change in EuroSCORE II? Eur J Cardiothorac Surg 2011;40:1304–8
  2. Hattler BG, Madia C, Johnson C, Armitage JM, Hardesty RL, Kormos RL, et al. Risk stratification using the Society of Thoracic Surgeons Program. Ann Thorac Surg 1994;58:1348–52
  3. Sanon S, Lee VV, Elayda MA, Gondi S, Livesay JJ, Reul GJ, et al. Predicting early death after cardiovascular surgery by using the Texas Heart Institute Risk Scoring Technique (THIRST). Tex Heart Inst J 2013;40:156–62
  4. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16:9–13
  5. Ranucci M, Castelvecchio S, Menicanti LA, Scolletta S, Biagioli B, Giomarelli P. An adjusted EuroSCORE model for high-risk cardiac patients. Eur J Cardiothorac Surg 2009;36:791–7
  6. Siregar S, Groenwold RH, de Heer F, Bots ML, van der Graaf Y, van Herwerden LA. Performance of the original EuroSCORE. Eur J Cardiothorac Surg 2012;41:746–54
  7. Roques F, Michel P, Goldstone AR, Nashef SA. The logistic EuroSCORE. Eur Heart J 2003;24:881–2
  8. Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, et al. EuroSCORE II. Eur J Cardiothorac Surg 2012;41:734– 44; discussion 744–5
  9. Grant SW, Grayson AD, Jackson M, Au J, Fabri BM, Grotte G, et al. Does the choice of risk-adjustment model influence the outcome of surgeon-specific mortality analysis? A retrospective analysis of 14,637 patients under 31 surgeons. Heart 2008;94:1044–9
  10. Zingone B, Pappalardo A, Dreas L. Logistic versus additive EuroSCORE. A comparative assessment of the two models in an independent population sample. Eur J Cardiothorac Surg 2004;26:1134–40
  11. Noyez L, Kievit PC, van Swieten HA, de Boer MJ. Cardiac operative risk evaluation: The EuroSCORE II, does it make a real difference? Neth Heart J 2012;20:494–8 12. Zhang GX, Wang C, Wang L, Lu FL, Li BL, Han L, et al. Validation of EuroSCORE II in Chinese patients undergoing heart valve surgery. Heart Lung Circ 2013;22:606–11
  12. Rabbani MS, Qadir I, Ahmed Y, Gul M, Sharif H. Heart valve surgery: EuroSCORE vs. EuroSCORE II vs. Society of Thoracic Surgeons score. Heart Int 2014;9:53–8
  13. Chalmers J, Pullan M, Fabri B, McShane J, Shaw M, Mediratta N, et al. Validation of EuroSCORE II in a modern cohort of patients undergoing cardiac surgery. Eur J Cardi